Affordable Access

deepdyve-link
Publisher Website

New-onset persistent left bundle branch block following sutureless aortic valve replacement.

Authors
  • Vilalta, Victoria1, 2
  • Cediel, Germán1
  • Mohammadi, Siamak3
  • López, Helena1
  • Kalavrouziotis, Dimitri3
  • Resta, Helena1
  • Dumont, Eric3
  • Voisine, Pierre3
  • Philippon, François3
  • Escabia, Claudia1
  • Borrellas, Andrea1
  • Alperi, Alberto3
  • Fernandez-Nofrerias, Eduard1
  • Carrillo, Xavier1
  • Panagides, Vassili3
  • Bayes-Genis, Antoni1, 2
  • Rodés-Cabau, Josep4
  • 1 Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. , (Spain)
  • 2 Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. , (Spain)
  • 3 Department of Cardiology and Cardiac Surgery, Quebec Heart and Lung Institute, Quebec City, Quebec, Canada. , (Canada)
  • 4 Department of Cardiology and Cardiac Surgery, Quebec Heart and Lung Institute, Quebec City, Quebec, Canada [email protected] , (Canada)
Type
Published Article
Journal
Heart
Publisher
BMJ
Publication Date
Jul 16, 2022
Identifiers
DOI: 10.1136/heartjnl-2022-321191
PMID: 35842233
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

To evaluate the incidence, predictive factors and prognostic value of new-onset persistent left bundle branch block (NOP-LBBB) in patients undergoing sutureless surgical aortic valve replacement (SU-SAVR). A total of 329 consecutive patients without baseline conduction disturbances or previous permanent pacemaker implantation (PPI) who underwent SU-SAVR with the Perceval valve (LivaNova Group, Saluggia, Italy) in two centres from 2013 to 2019 were included. Patients were on continuous ECG monitoring during hospitalisation and 12-lead ECG was performed after the procedure and at hospital discharge. NOP-LBBB was defined as a new postprocedural LBBB that persisted at hospital discharge. Baseline, procedural and follow-up clinical and echocardiography data were collected in a dedicated database. New-onset LBBB was observed in 115 (34.9%) patients, and in 76 (23.1%) persisted at hospital discharge. There were no differences in baseline and procedural characteristics between patients with (n=76) and without (n=253) NOP-LBBB. After a median follow-up of 3.3 years (2.3-4.4 years), patients with NOP-LBBB had a higher incidence of PPI (14.5% vs 6.3%, p=0.016), but exhibited similar rates of all-cause mortality (19.4% vs 19.2%, p=0.428), cardiac mortality (8.1% vs 9.4%, p=0.805) and heart failure readmission (21.0% vs 23.2%, p=0.648), compared with the no/transient LBBB group. NOP-LBBB was associated with a decrease in left ventricular ejection fraction (LVEF) at 1-year follow-up (delta: -5.7 vs +0.2, p<0.001). NOP-LBBB occurred in approximately a quarter of patients without prior conduction disturbances who underwent SU-SAVR and was associated with a threefold increased risk of PPI along with a negative impact on LVEF at follow-up. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Report this publication

Statistics

Seen <100 times